Types of anemia in hematological malignancy
DOI:
https://doi.org/10.18203/2320-6012.ijrms20251622Keywords:
Anemia, Thalassemia, Sickle cell anemiaAbstract
Background: Anemia is a condition where a person's hemoglobin or red blood cells (RBC) levels are inadequate. This disease affects about one-third of the population of the world. Anemia has been linked to higher morbidity and mortality rates in patients with hematological malignancies. This study aimed to investigate the causes and types of anemia in a group of patients with hematological malignancies at Hiwa Cancer Center, Sulaymaniyah, Iraq.
Methods: A total of 41 patients diagnosed with hematological malignancy were recruited. Relevant patient information was gathered. Their records, including demographic data, complete blood count (CBC) findings at presentation, blood films, and bone marrow slides, were reviewed and recorded. Furthermore, erythrocyte sedimentation rate, reticulocytes count, Coombs test, iron status, prothrombin time (PT), and activated partial thromboplastin time (APTT) were evaluated.
Results: Data of this study showed that the most prevalent hematological malignancy in 41 patients was chronic lymphocytic leukemia (24.4%) and the less prevalent form was multiple myeloma (5%). Furthermore, in our study, results showed that the most frequent type of anemia was normocytic (76%) and the least frequent form was macrocytic anemia (7%).
Conclusions: The current study proved that normocytic anemia is the most common type of anemia among patients with hematological malignancies.
Metrics
References
Amini RM, Enblad G. Relationship Between Hodgkin's and Non-Hodgkin's Lymphomas. Med Oncol. 2003;20(3):211-20,. DOI: https://doi.org/10.1385/MO:20:3:211
Hariz A, Bhattacharya PT. Megaloblastic Anemia. Treasure Island (FL): StatPearls Publishing. 2023.
Ansell SM. Hodgkin lymphoma: A 2020 update on diagnosis, risk-stratification, and management. Am J Hematol. 2020;95(8):978-89. DOI: https://doi.org/10.1002/ajh.25856
Vakiti A, Mewawalla P. Cancer, Acute Myeloid Leukemia (AML, Erythroid Leukemia, Myelodysplasia-Related Leukemia, BCR-ABL Chronic Leukemia). Treasure Island (FL): StatPearls Publishing. 2024.
Kohne E. Hemoglobinopathies. Dtsch Arztebl Int. 2011;108(31-32):532-40.
Belson M, Kingsley B, Holmes A. Risk factors for acute leukemia in children: a review. Environ Health Perspect. 2007;115(1):138-45. DOI: https://doi.org/10.1289/ehp.9023
Chaparro CM, Suchdev PS. Anemia epidemiology, pathophysiology, and etiology in low- and middle-income countries. Ann N Y Acad Sci. 2019;1450(1):15-31. DOI: https://doi.org/10.1111/nyas.14092
Dalton WS. Anemia in Multiple Myeloma and Its Management. Cancer Control. 1998;5(2):46-50. DOI: https://doi.org/10.1177/107327489800502s09
Dameshek W. Pernicious anemia, megaloblastosis and the di Guglielmo syndrome. Blood. 1958;13(11):1085-8. DOI: https://doi.org/10.1182/blood.V13.11.1085.1085
De Falco L, Sanchez M, Silvestri L, Kannengiesser C, Muckenthaler MU, Iolascon A, et al. Iron refractory iron deficiency anemia. Haematologica. 2013;98(6):845-53. DOI: https://doi.org/10.3324/haematol.2012.075515
Ghanem S, Gonsky J. Recurrent anemia in a patient with chronic lymphocytic leukemia. Cleve Clin J Med. 2022;89(2):91-8. DOI: https://doi.org/10.3949/ccjm.89a.21025
Goldin LR, Björkholm M, Kristinsson SY, Turesson I, Landgren O. Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia. Haematologica. 2009;94(5):647-53. DOI: https://doi.org/10.3324/haematol.2008.003632
Green AM, Kupfer GM. Fanconi anemia. Hematol Oncol Clin North Am. 2009;23(2):193-214. DOI: https://doi.org/10.1016/j.hoc.2009.01.008
Bajwa H, Basit H. Thalassemia. Treasure Island (FL): StatPearls Publishing. 2023.
Horesh N, Horowitz NA. Does gender matter in non-hodgkin lymphoma? Differences in epidemiology, clinical behavior, and therapy. Rambam Maimonides Med J. 2014;5(4):e0038. DOI: https://doi.org/10.5041/RMMJ.10172
Hohaus S, Massini G, Giachelia M, Vannata B, Bozzoli V, Cuccaro A, et al. Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin. J Clin Oncol. 2010;28(15):2538-43. DOI: https://doi.org/10.1200/JCO.2009.27.6873
Cannavale K, Xu H, Xu L, Sattayapiwat O, Rodriguez R, Bohac C, et al. Epidemiology of Chemotherapy-Induced Anemia in Patients with Non-Hodgkin Lymphoma. Perm J. 2019;23:18-252. DOI: https://doi.org/10.7812/TPP/18-252
Liu Z, Shi Y, Yan Z, He Z, Ding B, Tao S, et al. Impact of anemia on the outcomes of chronic phase chronic myeloid leukemia in TKI era. Hematology. 2020;25(1):181-5. DOI: https://doi.org/10.1080/16078454.2020.1765563
Madu AJ, Ughasoro MD. Anaemia of Chronic Disease: An In-Depth Review. Med Princ Pract. 2017;26(1):1-9. DOI: https://doi.org/10.1159/000452104
Marinescu C, Vlădăreanu AM, Mihai F. Acute Lymphocytic Leukemia in Adults. Pathologic Features and Prognosis. Rom J Intern Med. 2015;53(1):31-6. DOI: https://doi.org/10.1515/rjim-2015-0004
Massey AC. Microcytic anemia. Differential diagnosis and management of iron deficiency anemia. Med Clin North Am. 1992;76(3):549-66. DOI: https://doi.org/10.1016/S0025-7125(16)30339-X
Kileen RB, Adil A. Macrocytic Anemia. Treasure Island (FL): StatPearls Publishing. 2025.
World Health Organization. Anemia. Available at: https://www.who.int/health-topics/anaemia. Accessed on 12 March 2025.
Short MW, Domagalski JE. Iron deficiency anemia: evaluation and management. Am Fam Physician. 2013;87(2):98-104.
Soliman AT, De Sanctis V, Yassin M, Soliman N. Iron deficiency anemia and glucose metabolism. Acta Biomed. 2017;88(1):112-8.
Oo TH, Rojas-Hernandez CM. Challenging clinical presentations of pernicious anemia. Discov Med. 2017;24(131):107-15.
Padala SA, Barsouk A, Barsouk A, Rawla P, Vakiti A, Kolhe R, et al. Epidemiology, Staging, and Management of Multiple Myeloma. Med Sci (Basel). 2021;9(1):3. DOI: https://doi.org/10.3390/medsci9010003
Phillips J, Henderson AC. Hemolytic Anemia: Evaluation and Differential Diagnosis. Am Fam Physician. 2018;98(6):354-61.
Piel FB, Steinberg MH, Rees DC. Sickle Cell Disease. N Engl J Med. 2017;376(16):1561-73. DOI: https://doi.org/10.1056/NEJMra1510865
Vago L, Gojo I. Immune escape and immunotherapy of acute myeloid leukemia. J Clin Invest. 2020;130(4):1552-64. DOI: https://doi.org/10.1172/JCI129204
Puckett Y, Chan O. Cancer, Acute Lymphocytic Leukemia (ALL). Treasure Island (FL): StatPearls Publishing. 2023.
Yilmaz G, Shaikh H. Normochromic Normocytic Anemia. Treasure Island (FL): StatPearls Publishing. 2023.
Young NS. Aplastic Anemia. N Engl J Med. 2018;379(17):1643-56. DOI: https://doi.org/10.1056/NEJMra1413485
Downloads
Published
How to Cite
Issue
Section
